Industry Research Reports

Home > Reports > Chemical & Material > Global Moxidectin API Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Moxidectin API Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-10-22

Pages: 141 Pages

Report ld: 5198804

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Moxidectin API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Moxidectin is an anthelmintic drug which kills parasitic worms and is used for the prevention and control of heartworm and intestinal worms.

From a downstream perspective, Research accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Moxidectin API leading manufacturers including Tecoland, Pharmaffiliates, Jigs chemical, Haihang Industry, Hangzhou Keying Chem, Suzhou Howsine Biological Technology, Zhejiang Rongyao Biotech, Xi'an Harmonious Natural Biotechnology, etc., dominate supply; the top five capture approximately % of global revenue, with Tecoland leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Moxidectin API market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Tecoland
Pharmaffiliates
Jigs chemical
Haihang Industry
Hangzhou Keying Chem
Suzhou Howsine Biological Technology
Zhejiang Rongyao Biotech
Xi'an Harmonious Natural Biotechnology

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%

Segment by Application

Research
Pharmaceutical

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Moxidectin API study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Moxidectin API: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Moxidectin API Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Min Purity Less Than 98%

1.2.3 Min Purity 98%-99%

1.2.4 Min Purity More Than 99%

1.3 Market Segmentation by Application

1.3.1 Global Moxidectin API Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Research

1.3.3 Pharmaceutical

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Moxidectin API Revenue Estimates and Forecasts 2020-2031

2.2 Global Moxidectin API Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Moxidectin API Sales Estimates and Forecasts 2020-2031

2.4 Global Moxidectin API Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Moxidectin API Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

3.4.5 India

4 Competition by Manufacturers

4.1 Global Moxidectin API Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Moxidectin API Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Min Purity Less Than 98% Market Size by Manufacturers

4.5.2 Min Purity 98%-99% Market Size by Manufacturers

4.5.3 Min Purity More Than 99% Market Size by Manufacturers

4.6 Global Moxidectin API Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Moxidectin API Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Moxidectin API Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Moxidectin API Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Moxidectin API Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Moxidectin API Sales and Revenue by Type (2020-2031)

7.4 North America Moxidectin API Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Moxidectin API Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Moxidectin API Sales and Revenue by Type (2020-2031)

8.4 Europe Moxidectin API Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Moxidectin API Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Moxidectin API Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Moxidectin API Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Moxidectin API Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Moxidectin API Sales and Revenue by Type (2020-2031)

10.4 Central and South America Moxidectin API Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Moxidectin API Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Moxidectin API Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Moxidectin API Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Moxidectin API Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Tecoland

12.1.1 Tecoland Corporation Information

12.1.2 Tecoland Business Overview

12.1.3 Tecoland Moxidectin API Product Models, Descriptions and Specifications

12.1.4 Tecoland Moxidectin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Tecoland Moxidectin API Sales by Product in 2024

12.1.6 Tecoland Moxidectin API Sales by Application in 2024

12.1.7 Tecoland Moxidectin API Sales by Geographic Area in 2024

12.1.8 Tecoland Moxidectin API SWOT Analysis

12.1.9 Tecoland Recent Developments

12.2 Pharmaffiliates

12.2.1 Pharmaffiliates Corporation Information

12.2.2 Pharmaffiliates Business Overview

12.2.3 Pharmaffiliates Moxidectin API Product Models, Descriptions and Specifications

12.2.4 Pharmaffiliates Moxidectin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Pharmaffiliates Moxidectin API Sales by Product in 2024

12.2.6 Pharmaffiliates Moxidectin API Sales by Application in 2024

12.2.7 Pharmaffiliates Moxidectin API Sales by Geographic Area in 2024

12.2.8 Pharmaffiliates Moxidectin API SWOT Analysis

12.2.9 Pharmaffiliates Recent Developments

12.3 Jigs chemical

12.3.1 Jigs chemical Corporation Information

12.3.2 Jigs chemical Business Overview

12.3.3 Jigs chemical Moxidectin API Product Models, Descriptions and Specifications

12.3.4 Jigs chemical Moxidectin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Jigs chemical Moxidectin API Sales by Product in 2024

12.3.6 Jigs chemical Moxidectin API Sales by Application in 2024

12.3.7 Jigs chemical Moxidectin API Sales by Geographic Area in 2024

12.3.8 Jigs chemical Moxidectin API SWOT Analysis

12.3.9 Jigs chemical Recent Developments

12.4 Haihang Industry

12.4.1 Haihang Industry Corporation Information

12.4.2 Haihang Industry Business Overview

12.4.3 Haihang Industry Moxidectin API Product Models, Descriptions and Specifications

12.4.4 Haihang Industry Moxidectin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Haihang Industry Moxidectin API Sales by Product in 2024

12.4.6 Haihang Industry Moxidectin API Sales by Application in 2024

12.4.7 Haihang Industry Moxidectin API Sales by Geographic Area in 2024

12.4.8 Haihang Industry Moxidectin API SWOT Analysis

12.4.9 Haihang Industry Recent Developments

12.5 Hangzhou Keying Chem

12.5.1 Hangzhou Keying Chem Corporation Information

12.5.2 Hangzhou Keying Chem Business Overview

12.5.3 Hangzhou Keying Chem Moxidectin API Product Models, Descriptions and Specifications

12.5.4 Hangzhou Keying Chem Moxidectin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Hangzhou Keying Chem Moxidectin API Sales by Product in 2024

12.5.6 Hangzhou Keying Chem Moxidectin API Sales by Application in 2024

12.5.7 Hangzhou Keying Chem Moxidectin API Sales by Geographic Area in 2024

12.5.8 Hangzhou Keying Chem Moxidectin API SWOT Analysis

12.5.9 Hangzhou Keying Chem Recent Developments

12.6 Suzhou Howsine Biological Technology

12.6.1 Suzhou Howsine Biological Technology Corporation Information

12.6.2 Suzhou Howsine Biological Technology Business Overview

12.6.3 Suzhou Howsine Biological Technology Moxidectin API Product Models, Descriptions and Specifications

12.6.4 Suzhou Howsine Biological Technology Moxidectin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Suzhou Howsine Biological Technology Recent Developments

12.7 Zhejiang Rongyao Biotech

12.7.1 Zhejiang Rongyao Biotech Corporation Information

12.7.2 Zhejiang Rongyao Biotech Business Overview

12.7.3 Zhejiang Rongyao Biotech Moxidectin API Product Models, Descriptions and Specifications

12.7.4 Zhejiang Rongyao Biotech Moxidectin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 Zhejiang Rongyao Biotech Recent Developments

12.8 Xi'an Harmonious Natural Biotechnology

12.8.1 Xi'an Harmonious Natural Biotechnology Corporation Information

12.8.2 Xi'an Harmonious Natural Biotechnology Business Overview

12.8.3 Xi'an Harmonious Natural Biotechnology Moxidectin API Product Models, Descriptions and Specifications

12.8.4 Xi'an Harmonious Natural Biotechnology Moxidectin API Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 Xi'an Harmonious Natural Biotechnology Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Moxidectin API Industry Chain

13.2 Moxidectin API Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Moxidectin API Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Moxidectin API Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Moxidectin API Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Moxidectin API Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Moxidectin API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Moxidectin API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Moxidectin API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Moxidectin API Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Moxidectin API Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Moxidectin API Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)

Table 7. Global Moxidectin API Sales by Region (2020-2025) & (MT)

Table 8. Global Moxidectin API Sales by Region (2026-2031) & (MT)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Moxidectin API Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)

Table 11. Global Moxidectin API Production by Region (2020-2025) & (MT)

Table 12. Global Moxidectin API Production by Region (2026-2031) & (MT)

Table 13. Global Moxidectin API Sales by Manufacturers (2020-2025) & (MT)

Table 14. Global Moxidectin API Sales Share by Manufacturers (2020-2025)

Table 15. Global Moxidectin API Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Moxidectin API Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Moxidectin API by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Moxidectin API as of 2024)

Table 19. Global Moxidectin API Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Moxidectin API Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/MT)

Table 21. Key Manufacturers Moxidectin API Manufacturing Base and Headquarters

Table 22. Global Moxidectin API Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Moxidectin API Sales by Type (2020-2025) & (MT)

Table 26. Global Moxidectin API Sales by Type (2026-2031) & (MT)

Table 27. Global Moxidectin API Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Moxidectin API Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Moxidectin API ASP by Type (2020-2031) & (USD/MT)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Moxidectin API Sales by Application (2020-2025) & (MT)

Table 32. Global Moxidectin API Sales by Application (2026-2031) & (MT)

Table 33. Moxidectin API High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Moxidectin API Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Moxidectin API Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Moxidectin API ASP by Application (2020-2031) & (USD/MT)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Moxidectin API Growth Accelerators and Market Barriers

Table 40. North America Moxidectin API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Moxidectin API Sales (MT) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Moxidectin API Growth Accelerators and Market Barriers

Table 43. Europe Moxidectin API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Moxidectin API Sales (MT) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Moxidectin API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Moxidectin API Sales (MT) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Moxidectin API Growth Accelerators and Market Barriers

Table 48. Southeast Asia Moxidectin API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Moxidectin API Investment Opportunities and Key Challenges

Table 50. Central and South America Moxidectin API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Moxidectin API Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Moxidectin API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Tecoland Corporation Information

Table 54. Tecoland Description and Major Businesses

Table 55. Tecoland Product Models, Descriptions and Specifications

Table 56. Tecoland Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 57. Tecoland Sales Value Proportion by Product in 2024

Table 58. Tecoland Sales Value Proportion by Application in 2024

Table 59. Tecoland Sales Value Proportion by Geographic Area in 2024

Table 60. Tecoland Moxidectin API SWOT Analysis

Table 61. Tecoland Recent Developments

Table 62. Pharmaffiliates Corporation Information

Table 63. Pharmaffiliates Description and Major Businesses

Table 64. Pharmaffiliates Product Models, Descriptions and Specifications

Table 65. Pharmaffiliates Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 66. Pharmaffiliates Sales Value Proportion by Product in 2024

Table 67. Pharmaffiliates Sales Value Proportion by Application in 2024

Table 68. Pharmaffiliates Sales Value Proportion by Geographic Area in 2024

Table 69. Pharmaffiliates Moxidectin API SWOT Analysis

Table 70. Pharmaffiliates Recent Developments

Table 71. Jigs chemical Corporation Information

Table 72. Jigs chemical Description and Major Businesses

Table 73. Jigs chemical Product Models, Descriptions and Specifications

Table 74. Jigs chemical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 75. Jigs chemical Sales Value Proportion by Product in 2024

Table 76. Jigs chemical Sales Value Proportion by Application in 2024

Table 77. Jigs chemical Sales Value Proportion by Geographic Area in 2024

Table 78. Jigs chemical Moxidectin API SWOT Analysis

Table 79. Jigs chemical Recent Developments

Table 80. Haihang Industry Corporation Information

Table 81. Haihang Industry Description and Major Businesses

Table 82. Haihang Industry Product Models, Descriptions and Specifications

Table 83. Haihang Industry Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 84. Haihang Industry Sales Value Proportion by Product in 2024

Table 85. Haihang Industry Sales Value Proportion by Application in 2024

Table 86. Haihang Industry Sales Value Proportion by Geographic Area in 2024

Table 87. Haihang Industry Moxidectin API SWOT Analysis

Table 88. Haihang Industry Recent Developments

Table 89. Hangzhou Keying Chem Corporation Information

Table 90. Hangzhou Keying Chem Description and Major Businesses

Table 91. Hangzhou Keying Chem Product Models, Descriptions and Specifications

Table 92. Hangzhou Keying Chem Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 93. Hangzhou Keying Chem Sales Value Proportion by Product in 2024

Table 94. Hangzhou Keying Chem Sales Value Proportion by Application in 2024

Table 95. Hangzhou Keying Chem Sales Value Proportion by Geographic Area in 2024

Table 96. Hangzhou Keying Chem Moxidectin API SWOT Analysis

Table 97. Hangzhou Keying Chem Recent Developments

Table 98. Suzhou Howsine Biological Technology Corporation Information

Table 99. Suzhou Howsine Biological Technology Description and Major Businesses

Table 100. Suzhou Howsine Biological Technology Product Models, Descriptions and Specifications

Table 101. Suzhou Howsine Biological Technology Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 102. Suzhou Howsine Biological Technology Recent Developments

Table 103. Zhejiang Rongyao Biotech Corporation Information

Table 104. Zhejiang Rongyao Biotech Description and Major Businesses

Table 105. Zhejiang Rongyao Biotech Product Models, Descriptions and Specifications

Table 106. Zhejiang Rongyao Biotech Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 107. Zhejiang Rongyao Biotech Recent Developments

Table 108. Xi'an Harmonious Natural Biotechnology Corporation Information

Table 109. Xi'an Harmonious Natural Biotechnology Description and Major Businesses

Table 110. Xi'an Harmonious Natural Biotechnology Product Models, Descriptions and Specifications

Table 111. Xi'an Harmonious Natural Biotechnology Capacity, Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 112. Xi'an Harmonious Natural Biotechnology Recent Developments

Table 113. Key Raw Materials Distribution

Table 114. Raw Materials Key Suppliers

Table 115. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 116. Milestones in Production Technology Evolution

Table 117. Distributors List

Table 118. Market Trends and Market Evolution

Table 119. Market Drivers and Opportunities

Table 120. Market Challenges, Risks, and Restraints

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Moxidectin API Product Picture

Figure 2. Global Moxidectin API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Min Purity Less Than 98% Product Picture

Figure 4. Min Purity 98%-99% Product Picture

Figure 5. Min Purity More Than 99% Product Picture

Figure 6. Global Moxidectin API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Research

Figure 8. Pharmaceutical

Figure 9. Moxidectin API Report Years Considered

Figure 10. Global Moxidectin API Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 12. Global Moxidectin API Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Moxidectin API Revenue Market Share by Region (2020-2031)

Figure 14. Global Moxidectin API Sales (2020-2031) & (MT)

Figure 15. Global Moxidectin API Sales (CAGR) by Region (2020-2031) (MT)

Figure 16. Global Moxidectin API Sales Market Share by Region (2020-2031)

Figure 17. Global Moxidectin API Capacity, Production and Utilization (2020-2031) & (MT)

Figure 18. Global Moxidectin API Production Trend by Region (2020-2031) (MT)

Figure 19. Global Moxidectin API Production Market Share by Region (2020-2031)

Figure 20. Production Capacity Enablers & Constraints

Figure 21. Moxidectin API Production Growth Rate in North America (2020-2031) & (MT)

Figure 22. Moxidectin API Production Growth Rate in Europe (2020-2031) & (MT)

Figure 23. Moxidectin API Production Growth Rate in China (2020-2031) & (MT)

Figure 24. Moxidectin API Production Growth Rate in Japan (2020-2031) & (MT)

Figure 25. Moxidectin API Production Growth Rate in India (2020-2031) & (MT)

Figure 26. Top 5 and Top 10 Manufacturers Moxidectin API Sales Volume Market Share in 2024

Figure 27. Global Moxidectin API Revenue Market Share Ranking (2024)

Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 29. Min Purity Less Than 98% Revenue Market Share by Manufacturer in 2024

Figure 30. Min Purity 98%-99% Revenue Market Share by Manufacturer in 2024

Figure 31. Min Purity More Than 99% Revenue Market Share by Manufacturer in 2024

Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 34. Global Moxidectin API Sales Market Share by Type (2020-2031)

Figure 35. Global Moxidectin API Revenue Market Share by Type (2020-2031)

Figure 36. Global Moxidectin API Sales Market Share by Application (2020-2031)

Figure 37. Global Moxidectin API Revenue Market Share by Application (2020-2031)

Figure 38. North America Moxidectin API Sales YoY (2020-2031) & (MT)

Figure 39. North America Moxidectin API Revenue YoY (2020-2031) & (US$ Million)

Figure 40. North America Top 5 Manufacturers Moxidectin API Sales Revenue (US$ Million) in 2024

Figure 41. North America Moxidectin API Sales Volume (MT) by Type (2020- 2031)

Figure 42. North America Moxidectin API Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 43. North America Moxidectin API Sales Volume (MT) by Application (2020-2031)

Figure 44. North America Moxidectin API Sales Revenue (US$ Million) by Application (2020-2031)

Figure 45. US Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 46. Canada Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 47. Mexico Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 48. Europe Moxidectin API Sales YoY (2020-2031) & (MT)

Figure 49. Europe Moxidectin API Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Europe Top 5 Manufacturers Moxidectin API Sales Revenue (US$ Million) in 2024

Figure 51. Europe Moxidectin API Sales Volume (MT) by Type (2020-2031)

Figure 52. Europe Moxidectin API Sales Revenue (US$ Million) by Type (2020-2031)

Figure 53. Europe Moxidectin API Sales Volume (MT) by Application (2020-2031)

Figure 54. Europe Moxidectin API Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Germany Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 56. France Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 57. U.K. Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 58. Italy Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 59. Russia Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 60. Asia-Pacific Moxidectin API Sales YoY (2020-2031) & (MT)

Figure 61. Asia-Pacific Moxidectin API Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Asia-Pacific Top 8 Manufacturers Moxidectin API Sales Revenue (US$ Million) in 2024

Figure 63. Asia-Pacific Moxidectin API Sales Volume (MT) by Type (2020- 2031)

Figure 64. Asia-Pacific Moxidectin API Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 65. Asia-Pacific Moxidectin API Sales Volume (MT) by Application (2020-2031)

Figure 66. Asia-Pacific Moxidectin API Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Indonesia Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 68. Japan Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 69. South Korea Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 70. China Taiwan Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 71. India Moxidectin API Revenue (2020-2031) & (US$ Million)

Figure 72. Central and South America Moxidectin API Sales YoY (2020-2031) & (MT)

Figure 73. Central and South America Moxidectin API Revenue YoY (2020-2031) & (US$ Million)

Figure 74. Central and South America Top 5 Manufacturers Moxidectin API Sales Revenue (US$ Million) in 2024

Figure 75. Central and South America Moxidectin API Sales Volume (MT) by Type (2021-2031)

Figure 76. Central and South America Moxidectin API Sales Revenue (US$ Million) by Type (2020-2031)

Figure 77. Central and South America Moxidectin API Sales Volume (MT) by Application (2020-2031)

Figure 78. Central and South America Moxidectin API Sales Revenue (US$ Million) by Application (2020-2031)

Figure 79. Brazil Moxidectin API Revenue (2020-2025) & (US$ Million)

Figure 80. Argentina Moxidectin API Revenue (2020-2025) & (US$ Million)

Figure 81. Middle East, and Africa Moxidectin API Sales YoY (2020-2031) & (MT)

Figure 82. Middle East and Africa Moxidectin API Revenue YoY (2020-2031) & (US$ Million)

Figure 83. Middle East and Africa Top 5 Manufacturers Moxidectin API Sales Revenue (US$ Million) in 2024

Figure 84. Middle East and Africa Moxidectin API Sales Volume (MT) by Type (2021-2031)

Figure 85. South America Moxidectin API Sales Revenue (US$ Million) by Type (2020-2031)

Figure 86. Middle East and Africa Moxidectin API Sales Volume (MT) by Application (2020-2031)

Figure 87. Middle East and Africa Moxidectin API Sales Revenue (US$ Million) by Application (2020-2031)

Figure 88. GCC Countries Moxidectin API Revenue (2020-2025) & (US$ Million)

Figure 89. Turkey Moxidectin API Revenue (2020-2025) & (US$ Million)

Figure 90. Egypt Moxidectin API Revenue (2020-2025) & (US$ Million)

Figure 91. South Africa Moxidectin API Revenue (2020-2025) & (US$ Million)

Figure 92. Moxidectin API Industry Chain Mapping

Figure 93. Regional Moxidectin API Manufacturing Base Distribution (%)

Figure 94. Moxidectin API Production Process

Figure 95. Regional Moxidectin API Production Cost Structure

Figure 96. Channels of Distribution (Direct Vs Distribution)

Figure 97. Bottom-up and Top-down Approaches for This Report

Figure 98. Data Triangulation

Figure 99. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Moxidectin API market? zhanKai

The top companies in the global Moxidectin API market are Tecoland、Pharmaffiliates、Jigs chemical.

Related Reports

Moxidectin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Moxidectin API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 133
USD 3950.00
(Single User License)
Global Moxidectin API Market Research Report 2026
The global Moxidectin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 129
USD 2900.00
(Single User License)
Moxidectin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Moxidectin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 109
USD 3950.00
(Single User License)
Global Moxidectin API Market Research Report 2025
The global market for Moxidectin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 88
USD 2900.00
(Single User License)
Global Moxidectin API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Moxidectin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 80
USD 4250.00
(Single User License)
Global Moxidectin API Market Insights, Forecast to 2030
Moxidectin is an anthelmintic drug which kills parasitic worms and is used for the prevention and control of heartworm and intestinal worms.
Published Date: 2024-04-07
Pages: 95
USD 4900.00
(Single User License)
Moxidectin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Moxidectin is an anthelmintic drug which kills parasitic worms and is used for the prevention and control of heartworm and intestinal worms.
Published Date: 2024-02-19
Pages: 100
USD 3950.00
(Single User License)
Global Moxidectin API Market Research Report 2024
Moxidectin is an anthelmintic drug which kills parasitic worms and is used for the prevention and control of heartworm and intestinal worms.
Published Date: 2024-01-12
Pages: 94
USD 2900.00
(Single User License)

Moxidectin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Moxidectin API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 133
USD 3950.00 (Single User License)
Global Moxidectin API Market Research Report 2026
The global Moxidectin API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 129
USD 2900.00 (Single User License)
Moxidectin API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Moxidectin API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 109
USD 3950.00 (Single User License)
Global Moxidectin API Market Research Report 2025
The global market for Moxidectin API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 88
USD 2900.00 (Single User License)
Global Moxidectin API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Moxidectin API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 80
USD 4250.00 (Single User License)
Global Moxidectin API Market Insights, Forecast to 2030
Moxidectin is an anthelmintic drug which kills parasitic worms and is used for the prevention and control of heartworm and intestinal worms.
Published: 2024-04-07
Pages: 95
USD 4900.00 (Single User License)
Moxidectin API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Moxidectin is an anthelmintic drug which kills parasitic worms and is used for the prevention and control of heartworm and intestinal worms.
Published: 2024-02-19
Pages: 100
USD 3950.00 (Single User License)
Global Moxidectin API Market Research Report 2024
Moxidectin is an anthelmintic drug which kills parasitic worms and is used for the prevention and control of heartworm and intestinal worms.
Published: 2024-01-12
Pages: 94
USD 2900.00 (Single User License)